Who makes testosterone ophthalmic solution?

testosterone ophthalmic solution is developed by ORA, Inc..

What development phase is testosterone ophthalmic solution in?

testosterone ophthalmic solution is in Phase 2.

Last reviewed 2026-04-19 · How we verify

testosterone ophthalmic solution

ORA, Inc. · Phase 2 active Small molecule

At a glance

Generic name	testosterone ophthalmic solution
Sponsor	ORA, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

testosterone ophthalmic solution CI brief — competitive landscape report
testosterone ophthalmic solution updates RSS · CI watch RSS
ORA, Inc. portfolio CI